Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2018 1
2020 2
2021 1
2022 1
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.
Thomma RCM, Halstead SK, de Koning LC, Wiegers EEJA, Gourlay DS, Tio-Gillen AP, van Rijs W, Andersen H, Antonini G, Arends S, Attarian S, Barroso FA, Bateman KJ, Benedetti L, Van den Bergh P, Bürmann J, Busby M, Casasnovas C, Dardiotis E, Davidson A, Feasby TE, Fehmi J, Galassi G, Garcia-Sobrino T, Granit V, Gutiérrez-Gutiérrez G, Hadden RDM, Harbo T, Hartung HP, Hasan I, Holt JKL, Islam Z, Karafiath S, Katzberg HD, Kolb N, Kusunoki S, Kuwabara S, Kuwahara M, Lehmann HC, Leonhard SE, Martín-Aguilar L, Monges S, Nobile-Orazio E, Pardo J, Pereon Y, Querol L, Reisin RC, Rinaldi S, Ripellino P, Roberts RC, Scheidegger O, Shahrizaila N, Sheikh KA, Silvestri NJ, Sindrup SH, Stein B, Tan CY, Tankisi H, Visser LH, Waheed W, Huizinga R, Jacobs BC, Willison HJ; IGOS consortium. Thomma RCM, et al. Brain. 2025 Mar 17:awaf102. doi: 10.1093/brain/awaf102. Online ahead of print. Brain. 2025. PMID: 40096525 Free article.
Basic Pathological Mechanisms in Peripheral Nerve Diseases.
Schenone A, Massucco S, Schenone C, Venturi CB, Nozza P, Prada V, Pomili T, Di Patrizi I, Capodivento G, Nobbio L, Grandis M. Schenone A, et al. Among authors: capodivento g. Int J Mol Sci. 2025 Apr 4;26(7):3377. doi: 10.3390/ijms26073377. Int J Mol Sci. 2025. PMID: 40244242 Free PMC article. Review.
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies.
Capodivento G, Visigalli D, Garnero M, Fancellu R, Ferrara MD, Basit A, Hamid Z, Pastore VP, Garibaldi S, Armirotti A, Mancardi G, Serrati C, Capello E, Schenone A, Nobbio L. Capodivento G, et al. Sci Rep. 2017 Aug 10;7(1):7831. doi: 10.1038/s41598-017-08314-1. Sci Rep. 2017. PMID: 28798317 Free PMC article.
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment.
Fiorillo C, Capodivento G, Geroldi A, Tozza S, Moroni I, Mohassel P, Cataldi M, Campana C, Morando S, Panicucci C, Pedemonte M, Brolatti N, Siliquini S, Traverso M, Baratto S, Debellis D, Magri S, Prada V, Bellone E, Salpietro V, Donkervoort S, Gable K, Gupta SD, Dunn TM, Bönnemann CG, Taroni F, Bruno C, Schenone A, Mandich P, Nobbio L, Nolano M. Fiorillo C, et al. Among authors: capodivento g. Neuropathol Appl Neurobiol. 2022 Dec;48(7):e12842. doi: 10.1111/nan.12842. Epub 2022 Aug 10. Neuropathol Appl Neurobiol. 2022. PMID: 35904184 Free PMC article.
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.
Capodivento G, De Michelis C, Carpo M, Fancellu R, Schirinzi E, Severi D, Visigalli D, Franciotta D, Manganelli F, Siciliano G, Beronio A, Capello E, Lanteri P, Nobile-Orazio E, Schenone A, Benedetti L, Nobbio L. Capodivento G, et al. J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):303-310. doi: 10.1136/jnnp-2020-324445. Epub 2020 Oct 22. J Neurol Neurosurg Psychiatry. 2021. PMID: 33093191 Free PMC article.
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.
Massa F, Vigo T, Bellucci M, Giunti D, Emanuela MM, Visigalli D, Capodivento G, Cerne D, Assini A, Boni S, Rizzi D, Narciso E, Grisanti GS, Coco E, Uccelli A, Schenone A, Franciotta D, Benedetti L. Massa F, et al. Among authors: capodivento g. Neurol Sci. 2024 Mar;45(3):849-859. doi: 10.1007/s10072-023-07279-6. Epub 2024 Jan 3. Neurol Sci. 2024. PMID: 38169013
A Comprehensive Description of the Roadmap to Identify and Validate a Myelin Biomarker.
Capodivento G, Visigalli D, Armirotti A, Demichelis C, Carpo M, Fancellu R, Schirinzi E, Severi D, Franciotta D, Manganelli F, Siciliano G, Beronio A, Capello E, Lanteri P, Nobile-Orazio E, Schenone A, Benedetti L, Nobbio L. Capodivento G, et al. Biomark Insights. 2025 Jul 6;20:11772719251349605. doi: 10.1177/11772719251349605. eCollection 2025. Biomark Insights. 2025. PMID: 40625699 Free PMC article.
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A.
Visigalli D, Capodivento G, Basit A, Fernández R, Hamid Z, Pencová B, Gemelli C, Marubbi D, Pastorino C, Luoma AM, Riekel C, Kirschner DA, Schenone A, Fernández JA, Armirotti A, Nobbio L. Visigalli D, et al. Among authors: capodivento g. Front Neurol. 2020 Aug 25;11:903. doi: 10.3389/fneur.2020.00903. eCollection 2020. Front Neurol. 2020. PMID: 32982928 Free PMC article.
12 results